Trinity Biotech | TRIB - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 6.65B 787M 2026-06
Bayer EUR 6.33B 1.84B 2026-06
Bio-Rad Laboratories USD 345.8M 36.4M 2026-06
EDAP TMS EUR 8.15M 2.17M 2026-03
J&J USD 18.55B 1.31B 2026-06
Mesa Laboratories USD 39.75M 4.3M 2024-12
OraSure Technologies USD 11.34M 435K 2025-12
Plus Therapeutics 1.37M 30K 2025-12
Roche Holding CHF 22.69B 600M 2026-06
Siemens EUR 7.68B 51M 2026-03
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Tosoh JPY 67.57B 10.89B 2025-09
Trinity Biotech USD 6.47M 1.59M 2025-09
Veracyte USD 108.55M 7.39M 2026-06